Physician profile
Christine W Mansfield
NPI 1124236781
$20,448.44
in general payments reported to CMS, 2019-2025
9 companies · $8,395 in 2025
The $8,395 reported for 2025 was more than what 96% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $321 · 2021: $93.95 · 2022: $341 · 2023: $5,071 · 2024: $5,781 · 2025: $8,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,301 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,597 · Travel and Lodging: $3,536 · Food and Beverage: $1,814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,301.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,596.85 |
| Travel and Lodging | $3,535.79 |
| Food and Beverage | $1,813.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $19,620.89 | 2019-2025 | Menopur |
| Emd Serono, INC. | $254.78 | 2019-2020 | |
| Abbvie INC. | $159.28 | 2019-2020 | |
| Organon LLC | $155.82 | 2022-2025 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Hologic Sales and Service, LLC | $116.61 | 2019-2025 | Myosure Tissue Removal Device, Novasure |
| Merck Sharp & Dohme LLC | $55.50 | 2019-2020 | |
| Minerva Surgical, INC | $40.17 | 2024 | |
| Vitrolife INC. | $24.36 | 2021 | |
| Coopersurgical, INC. | $21.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Mansfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.